<unk> , sold under the brand name Nucala, is a humanized monoclonal antibody used for the treatment of severe eosinophilic asthma, eosinophilic granulomatosis, and hypereosinophilic syndrome (HES). It recognizes and blocks interleukin-5 (IL-5), a signalling protein of the immune system. The most common side effects include headache, injection site reactions, and back pain.
Mepolizumab
Vedolizumab
Certolizumab pegol
Nemolizumab
Natalizumab
Belatacept
Brolucizumab
Reslizumab